152 related articles for article (PubMed ID: 18552510)
1. No evidence of an association between norepinephrine transporter gene polymorphisms and attention deficit hyperactivity disorder: a family-based and case-control association study in a Korean sample.
Cho SC; Kim JW; Kim BN; Hwang JW; Park M; Kim SA; Cho DY; Yoo HJ; Chung US; Son JW; Park TW
Neuropsychobiology; 2008; 57(3):131-8. PubMed ID: 18552510
[TBL] [Abstract][Full Text] [Related]
2. A haplotype of the norepinephrine transporter gene (SLC6A2) is associated with visual memory in attention-deficit/hyperactivity disorder.
Shang CY; Chiang HL; Gau SS
Prog Neuropsychopharmacol Biol Psychiatry; 2015 Apr; 58():89-96. PubMed ID: 25554436
[TBL] [Abstract][Full Text] [Related]
3. Possible effect of norepinephrine transporter polymorphisms on methylphenidate-induced changes in neuropsychological function in attention-deficit hyperactivity disorder.
Park S; Kim JW; Yang YH; Hong SB; Park MH; Kim BN; Shin MS; Yoo HJ; Cho SC
Behav Brain Funct; 2012 May; 8():22. PubMed ID: 22591463
[TBL] [Abstract][Full Text] [Related]
4. The 1287 G/A polymorphism of the norepinephrine transporter gene (NET) is involved in commission errors in Korean children with attention deficit hyperactivity disorder.
Song DH; Jhung K; Song J; Cheon KA
Behav Brain Funct; 2011 May; 7():12. PubMed ID: 21569456
[TBL] [Abstract][Full Text] [Related]
5. Association between the alpha-2C-adrenergic receptor gene and attention deficit hyperactivity disorder in a Korean sample.
Cho SC; Kim JW; Kim BN; Hwang JW; Shin MS; Park M; Kim SA; Cho DY; Yoo HJ; Chung US; Son JW; Park TW
Neurosci Lett; 2008 Dec; 446(2-3):108-11. PubMed ID: 18835330
[TBL] [Abstract][Full Text] [Related]
6. Norepinephrine transporter gene (SLC6A2) is involved with methylphenidate response in Korean children with attention deficit hyperactivity disorder.
Song J; Song DH; Jhung K; Cheon KA
Int Clin Psychopharmacol; 2011 Mar; 26(2):107-13. PubMed ID: 21127421
[TBL] [Abstract][Full Text] [Related]
7. Association studies of -3081(A/T) polymorphism of norepinephrine transporter gene with attention deficit/hyperactivity disorder in Korean population.
Joung Y; Kim CH; Moon J; Jang WS; Yang J; Shin D; Lee S; Kim KS
Am J Med Genet B Neuropsychiatr Genet; 2010 Mar; 153B(2):691-694. PubMed ID: 19685476
[TBL] [Abstract][Full Text] [Related]
8. Association analysis of norepinephrine transporter polymorphisms and methylphenidate response in ADHD patients.
Angyal N; Horvath EZ; Tarnok Z; Richman MJ; Bognar E; Lakatos K; Sasvari-Szekely M; Nemoda Z
Prog Neuropsychopharmacol Biol Psychiatry; 2018 Jun; 84(Pt A):122-128. PubMed ID: 29374517
[TBL] [Abstract][Full Text] [Related]
9. Possible association of norepinephrine transporter -3081(A/T) polymorphism with methylphenidate response in attention deficit hyperactivity disorder.
Kim BN; Kim JW; Hong SB; Cho SC; Shin MS; Yoo HJ
Behav Brain Funct; 2010 Oct; 6():57. PubMed ID: 20929549
[TBL] [Abstract][Full Text] [Related]
10. The possible involvement of genetic variants of NET1 in the etiology of attention-deficit/hyperactivity disorder comorbid with oppositional defiant disorder.
Liu L; Cheng J; Li H; Yang L; Qian Q; Wang Y
J Child Psychol Psychiatry; 2015 Jan; 56(1):58-66. PubMed ID: 24942521
[TBL] [Abstract][Full Text] [Related]
11. [Association between serotonin 2C gene polymorphisms and attention deficit hyperactivity disorder in children with or without comorbidity of disruptive behavior disorder].
Li J; Wang YF; Zhou RL; Yang L; Zhang HB; Wang B
Zhonghua Er Ke Za Zhi; 2007 May; 45(5):374-7. PubMed ID: 17697626
[TBL] [Abstract][Full Text] [Related]
12. Norepinephrine transporter and catecholamine-O-methyltransferase gene variants and attention-deficit/hyperactivity disorder symptoms in adults.
Retz W; Rösler M; Kissling C; Wiemann S; Hünnerkopf R; Coogan A; Thome J; Freitag C
J Neural Transm (Vienna); 2008; 115(2):323-9. PubMed ID: 17994190
[TBL] [Abstract][Full Text] [Related]
13. No evidence for association between a functional promoter variant of the Norepinephrine Transporter gene SLC6A2 and ADHD in a family-based sample.
Renner TJ; Nguyen TT; Romanos M; Walitza S; Röser C; Reif A; Schäfer H; Warnke A; Gerlach M; Lesch KP
Atten Defic Hyperact Disord; 2011 Sep; 3(3):285-9. PubMed ID: 21739117
[TBL] [Abstract][Full Text] [Related]
14. Norepinephrine transporter -3081(A/T) and alpha-2A-adrenergic receptor MspI polymorphisms are associated with cardiovascular side effects of OROS-methylphenidate treatment.
Cho SC; Kim BN; Cummins TD; Kim JW; Bellgrove MA
J Psychopharmacol; 2012 Mar; 26(3):380-9. PubMed ID: 21628343
[TBL] [Abstract][Full Text] [Related]
15. Norepinephrine genes predict response time variability and methylphenidate-induced changes in neuropsychological function in attention deficit hyperactivity disorder.
Kim BN; Kim JW; Cummins TD; Bellgrove MA; Hawi Z; Hong SB; Yang YH; Kim HJ; Shin MS; Cho SC; Kim JH; Son JW; Shin YM; Chung US; Han DH
J Clin Psychopharmacol; 2013 Jun; 33(3):356-62. PubMed ID: 23609393
[TBL] [Abstract][Full Text] [Related]
16. A haplotype of the norepinephrine transporter (Net) gene Slc6a2 is associated with clinical response to atomoxetine in attention-deficit hyperactivity disorder (ADHD).
Ramoz N; Boni C; Downing AM; Close SL; Peters SL; Prokop AM; Allen AJ; Hamon M; Purper-Ouakil D; Gorwood P
Neuropsychopharmacology; 2009 Aug; 34(9):2135-42. PubMed ID: 19387424
[TBL] [Abstract][Full Text] [Related]
17. Replication of a rare protective allele in the noradrenaline transporter gene and ADHD.
Xu X; Hawi Z; Brookes KJ; Anney R; Bellgrove M; Franke B; Barry E; Chen W; Kuntsi J; Banaschewski T; Buitelaar J; Ebstein R; Fitzgerald M; Miranda A; Oades RD; Roeyers H; Rothenberger A; Sergeant J; Sonuga-Barke E; Steinhausen HC; Faraone SV; Gill M; Asherson P
Am J Med Genet B Neuropsychiatr Genet; 2008 Dec; 147B(8):1564-7. PubMed ID: 18937296
[TBL] [Abstract][Full Text] [Related]
18. Regional brain perfusion before and after treatment with methylphenidate may be associated with the G1287A polymorphism of the norepinephrine transporter gene in children with attention-deficit/hyperactivity disorder.
Park MH; Kim JW; Yang YH; Hong SB; Park S; Kang H; Kim BN; Shin MS; Yoo HJ; Cho SC
Neurosci Lett; 2012 Apr; 514(2):159-63. PubMed ID: 22405810
[TBL] [Abstract][Full Text] [Related]
19. Association of SNAP-25, SLC6A2, and LPHN3 with OROS methylphenidate treatment response in attention-deficit/hyperactivity disorder.
Song J; Kim SW; Hong HJ; Lee MG; Lee BW; Choi TK; Lee SH; Yook KH
Clin Neuropharmacol; 2014; 37(5):136-41. PubMed ID: 25229170
[TBL] [Abstract][Full Text] [Related]
20. Lack of association between response of OROS-methylphenidate and norepinephrine transporter (SLC6A2) polymorphism in Korean ADHD.
Lee SH; Kim SW; Lee MG; Yook KH; Greenhill LL; Fradin KN; Hong HJ
Psychiatry Res; 2011 Apr; 186(2-3):338-44. PubMed ID: 20863575
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
